The life sciences sector is at a crossroads as the FDA updates quality management standards. AI is now expected, and the FDA’s January 2025 draft guidance outlines its evaluation and implementation. Successful adoption depends on three key questions.
Safe and Sane: Understanding the FDA’s Risk-Based Approach to AI
Related Posts
Podcast: Create a Culture of Excellence
Quality spoke with Praveen Gupta about how to expect excellence, strive for defect free manufacturing, and link the…
Prophesee Appoints Ferré CEO
Prophesee announced the appointment of Jean Ferré as Chief Executive Officer.
Beyond Calibration: What a Calibration Sticker May (And May Not) Tell You
Gages need calibration, but an annual calibration sticker can mislead non-experts. In addition to regular calibration, proper maintenance,…